Compugen (CGEN) Non-Current Deffered Revenue (2013 - 2026)

Compugen (CGEN) reported Non-Current Deffered Revenue of $22.1 million for Q1 2026, down 30.31% on a YoY basis from $31.8 million in Q1 2025, and down 11.24% sequentially from $24.9 million in Q4 2025.

Compugen (CGEN) Non-Current Deffered Revenue (2013 - 2026) Analysis & Trends

Compugen (CGEN) has 5 years of Non-Current Deffered Revenue data on file, last reported at $22.1 million in Q1 2026.

  • For the quarter ending Q1 2026, Non-Current Deffered Revenue fell 30.31% year-over-year to $22.1 million; the trailing twelve-month figure through Mar 2026 stood at $22.1 million (down 30.31% YoY), and the FY2025 full-year result was $24.9 million, down 26.74% from the prior year.
  • Non-Current Deffered Revenue retreated to $22.1 million in Q1 2026, from $24.9 million in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $34.0 million in Q4 2024 to a low of $21.0 million in Q2 2024.
  • A 4-year average of $26.9 million and a median of $26.5 million in 2023 frame the typical range for Non-Current Deffered Revenue.
  • Across the five-year window, Non-Current Deffered Revenue jumped 40.73% in 2025 and plunged 30.31% in 2026, its largest moves.
  • Tracing CGEN's Non-Current Deffered Revenue over 4 years: stood at $25.4 million in 2023, then surged by 34.08% to $34.0 million in 2024, then declined by 26.74% to $24.9 million in 2025, then fell by 11.24% to $22.1 million in 2026.
  • Business Quant data shows CGEN's Non-Current Deffered Revenue at $22.1 million in Q1 2026, $24.9 million in Q4 2025, and $27.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 225.10 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Compugen 221.26 Mn 129.51 Mn 352,000.00 22.14 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 22.14 Mn
Dec 31, 2025 24.94 Mn
Sep 30, 2025 27.57 Mn
Jun 30, 2025 29.59 Mn
Mar 31, 2025 31.77 Mn
Dec 31, 2024 34.05 Mn
Sep 30, 2024 29.24 Mn
Jun 30, 2024 21.03 Mn
Mar 31, 2024 23.23 Mn
Dec 31, 2023 25.39 Mn
Dec 31, 2013 1.45 Mn